Eva Giné

44.2k total citations
107 papers, 3.0k citations indexed

About

Eva Giné is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Eva Giné has authored 107 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pathology and Forensic Medicine, 55 papers in Genetics and 52 papers in Oncology. Recurrent topics in Eva Giné's work include Lymphoma Diagnosis and Treatment (86 papers), Chronic Lymphocytic Leukemia Research (53 papers) and Viral-associated cancers and disorders (28 papers). Eva Giné is often cited by papers focused on Lymphoma Diagnosis and Treatment (86 papers), Chronic Lymphocytic Leukemia Research (53 papers) and Viral-associated cancers and disorders (28 papers). Eva Giné collaborates with scholars based in Spain, United States and Germany. Eva Giné's co-authors include Elı́as Campo, Neus Villamor, Francesc Bosch, Emili Montserrat, Armando López‐Guillermo, Dolors Colomer, Ana Muntañola, Jordi Esteve, Antonio Martı́nez and Marı́a Rozman and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Eva Giné

103 papers receiving 3.0k citations

Peers

Countries citing papers authored by Eva Giné

Since Specialization

Citations

This map shows the geographic impact of Eva Giné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Giné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Giné more than expected).

Fields of papers citing papers by Eva Giné

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Giné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Giné. The network helps show where Eva Giné may publish in the future.

Co-authorship network of co-authors of Eva Giné

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Giné. A scholar is included among the top collaborators of Eva Giné based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Giné. Eva Giné is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trials in Progress: Carman - an International, Randomized Phase II Study Evaluating Early Treatment Intensification in Patients with High Risk Mantle Cell Lymphoma Using CAR-T-Cell Treatment after an Abbreviated Induction Therapy with Rituximab and Ibrutinib and 6 Months Ibrutinib Maintenance (Arm A) As Compared to Standard of Care Induction and Maintenance (Arm B) 2024 ·Blood ·(unknown), Christian Schmidt, Marek Trněný, Eva Giné, Olivier Hermine, Anke Ohler, (unknown), (unknown), Eva Hoster, Christiane Pott, Martin Dreyling, Georg Heß	2
2	Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell–like Type: Phase II Clinical Trial of the Spanish GELTAMO Group 2024 ·Clinical Cancer Research ·(unknown), Carlos Grande, (unknown), (unknown), Antonio Gutiérrez, Ángel Ramírez Páyer, Eva Giné, (unknown), María José Terol, (unknown), Rafael Andreu, (unknown), Adolfo de la Fuente, María C. Viguria, María Jesús Peñarrubia, Ana Jiménez Ubieto, Santiago Montes‐Moreno, Armando López‐Guillermo, (unknown), Alejandro Martı́n	0
3	MCL-339 GLOBRYTE: A Phase III, Open-label Multicenter, Randomized Trial Evaluating Glofitamab Monotherapy in Patients with Relapsed or Refractory Mantle Cell Lymphoma 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Tycel Phillips, Matthew J. Matasar, Toby A. Eyre, Eva Giné, (unknown), Ben Byrne, Linda Lundberg, (unknown), Christophe Boetsch, Alessia Bottos, Naseer Qayum	1
4	A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses 2023 ·Leukemia ·(unknown), (unknown), Juan García Valero, Ferran Nadeu, (unknown), (unknown), (unknown), Renaud Morin, (unknown), Neus Serrat, (unknown), (unknown), Elı́as Campo, Jean‐Michel Lagarde, Armando López‐Guillermo, Eva Giné, Dolors Colomer, Christine Bezombes, Patricia Pérez‐Galán	17
5	Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma 2022 ·Leukemia ·(unknown), Patricia Balsas, (unknown), Ferran Nadeu, (unknown), Álvaro Eguileor, Marta Kulis, Giancarlo Castellano, Cristina López, Eva Giné, Santiago Demajo, Pedro Jares, José I. Martı́n-Subero, Sı́lvia Beà, Elı́as Campo, Virginia Amador	4
6	SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma 2021 ·Blood ·Patricia Balsas, Luis Veloza, Guillem Clot, (unknown), (unknown), Christos Masaoutis, Gerard Frigola, Alba Navarro, Sı́lvia Beà, Ferran Nadeu, Eva Giné, Armando López‐Guillermo, Antonio Martı́nez, Inmaculada Ribera‐Cortada, Pablo Engel, Leticia Quintanilla-Martı́nez, Wolfram Klapper, Elı́as Campo, Virginia Amador	32
7	A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma 2020 ·Clinical Cancer Research ·Santiago Demajo, (unknown), Guillem Clot, Giancarlo Castellano, Alba Navarro, (unknown), Anna Enjuanes, Ferran Nadeu, Eva Giné, Magda Pinyol, Elaine S. Jaffe, German Ott, Louis M. Staudt, Andreas Rosenwald, David W. Scott, Lisa M. Rimsza, Armando López‐Guillermo, Sı́lvia Beà, Elı́as Campo, Pedro Jares	10
8	The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients 2020 ·European Journal Of Haematology ·Pablo Mozas, Marc Sorigué, Alfredo Rivas‐Delgado, Andrea Rivero, Juan Gonzalo Correa, (unknown), Ferran Nadeu, Álex Bataller, Eva Giné, Tycho Baumann, Julio Delgado, Neus Villamor, Elı́as Campo, Laura Magnano, Juan‐Manuel Sancho, Armando López‐Guillermo	1
9	Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports 2020 ·Transfusion ·(unknown), Joan Cid, (unknown), Eva Giné, Alberto Álvarez‐Larrán, María Teresa Cibeira, Miquel Lozano	2
10	High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma 2017 ·Leukemia Research ·Iván Dlouhy, Xavier Filella, Jordina Rovira, Laura Magnano, Alfredo Rivas‐Delgado, Tycho Baumann, Alejandra Martínez‐Trillos, Olga Balagué, Antonio Martı́nez, Blanca González‐Farré, Kennosuke Karube, Eva Giné, Julio Delgado, Elı́as Campo, Armando López‐Guillermo	38
11	The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia 2016 ·Clinical Cancer Research ·Alba Matas‐Céspedes, (unknown), Vanina Rodríguez, Neus Villamor, Julio Delgado, Eva Giné, Heleia Roca-Ho, Pablo Menéndez, Elı́as Campo, Armando López‐Guillermo, Dolors Colomer, Gaël Roué, Adrian Wiestner, Paul W.H.I. Parren, Parul Doshi, Jeroen Lammerts van Bueren, Patricia Pérez‐Galán	45
12	MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome 2016 ·Clinical Cancer Research ·Jordina Rovira, Kennosuke Karube, Alexandra Valera, Dolors Colomer, Anna Enjuanes, Luís Colomo, Alejandra Martínez‐Trillos, Eva Giné, Iván Dlouhy, Laura Magnano, Julio Delgado, Antonio Martı́nez, Neus Villamor, Elı́as Campo, Armando López‐Guillermo	50
13	Disruption of Follicular Dendritic Cells–Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib) 2014 ·Clinical Cancer Research ·Alba Matas‐Céspedes, Vanina Rodríguez, Susana G. Kalko, (unknown), Laia Rosich, (unknown), Patricia Balsas, Neus Villamor, Eva Giné, Elı́as Campo, Gaël Roué, Armando López‐Guillermo, Dolors Colomer, Patricia Pérez‐Galán	21
14	Varón de 28 años con hepatoesplenomegalia y fiebre 2014 ·Medicina Clínica ·Ana Muntañola, Sónia Rodríguez, Eva Giné	0
15	Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evaluating the Immunoconjugate Inotuzumab Ozogamicin With Rituximab 2013 ·Journal of Clinical Oncology ·Luis Fayad, Fritz Offner, Mitchell R. Smith, Gregor Verhoef, Peter Johnson, Jonathan L. Kaufman, A. Z. S. Rohatiner, Anjali S. Advani, James M. Foran, Georg Heß, Bertrand Coiffier, Myron S. Czuczman, Eva Giné, Simon Durrant, Michelle Kneissl, Kenneth T. Luu, Steven Y. Hua, Joseph Boni, Erik Vandendries, Nam H. Dang	119
16	Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network 2013 ·Annals of Oncology ·Chan Y. Cheah, Anupkumar George, Eva Giné, Annalisa Chiappella, Hanneke C. Kluin‐Nelemans, Wojciech Jurczak, Katarzyna Krawczyk, Heidi Móciková, Pavel Klener, D. Šálek, Jan Walewski, Michał Szymczyk, Lukáš Smolej, Rebecca Auer, David Ritchie, Luca Arcaini, Michael E. Williams, Martin Dreyling, John F. Seymour	83
17	Differential Gene Expression Profile Associated to Apoptosis Induced by Dexamethasone in CLL Cells According to IGHV/ZAP-70 Status 2012 ·Clinical Cancer Research ·Maria João Baptista, Ana Muntañola, (unknown), Pau Abrisqueta, Olga Salamero, (unknown), Carles Codony, Eva Giné, Susana G. Kalko, Marta Crespo, Francesc Bosch	4
18	Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study 2010 ·Journal of Clinical Oncology ·Anjali S. Advani, Bertrand Coiffier, Myron S. Czuczman, Martin Dreyling, James M. Foran, Eva Giné, Christian Gisselbrecht, Nicolas Ketterer, Sunita D. Nasta, A. Z. S. Rohatiner, Ingo G.H. Schmidt‐Wolf, Martin Schüler, Jorge Sierra, Mitchell R. Smith, Gregor Verhoef, Jane N. Winter, Joseph Boni, Erik Vandendries, Mark Shapiro, Luis Fayad	255
19	Anti-CD22 immunoconjugate inotuzumab ozogamicin (CMC-544) + rituximab: clinical activity in patients with relapsed/refractory follicular or 'aggressive' lymphoma 2010 ·Ghent University Academic Bibliography (Ghent University) ·Gregor Verhoef, (unknown), Mitchell R. Smith, (unknown), Peter Johnson, A. Z. S. Rohatiner, (unknown), Eva Giné, B Coiffier, M. S. Czuczman, James M. Foran, Simon Durrant, Steven Y. Hua, Erik Vandendries, Joseph Boni, Luis Fayad	2
20	High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission 2004 ·Bone Marrow Transplantation ·E. Nadal, Eva Giné, Joan Bladé, Jordi Esteve, Laura Rosiñol, Francesc Fernández‐Avilés, Pedro Marı́n, Carmen Martı́nez, Montserrat Rovira, Álvaro Urbano-Ispizúa, Enric Carreras, E Montserrat	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact